Variant report
Variant | nsv584010 |
---|---|
Chromosome Location | chr2:186205189-186245653 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs850880 | chr2:186205189-186205190 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189904637 | chr2:186205283-186205284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534073881 | chr2:186205292-186205293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538154248 | chr2:186205329-186205330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182130330 | chr2:186205375-186205376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142642411 | chr2:186205399-186205400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188402832 | chr2:186205400-186205401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556347554 | chr2:186205494-186205495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192736943 | chr2:186205506-186205507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72904785 | chr2:186205528-186205529 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs553871289 | chr2:186205559-186205560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184793994 | chr2:186205653-186205654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542897216 | chr2:186205672-186205673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188398383 | chr2:186205698-186205699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556172313 | chr2:186205699-186205700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144782776 | chr2:186205720-186205721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72904786 | chr2:186205724-186205725 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs561377283 | chr2:186205731-186205732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532873896 | chr2:186205732-186205733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192002144 | chr2:186205769-186205770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566456654 | chr2:186205826-186205827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527320997 | chr2:186205830-186205831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185081430 | chr2:186205845-186205846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201207577 | chr2:186205930-186205931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189448098 | chr2:186205940-186205941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76291637 | chr2:186205946-186205947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538146835 | chr2:186205975-186205976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180963028 | chr2:186205976-186205977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540763187 | chr2:186206000-186206001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184248452 | chr2:186206014-186206015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs850881 | chr2:186206027-186206028 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs554274661 | chr2:186206046-186206047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369500556 | chr2:186206050-186206051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs850882 | chr2:186206092-186206093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs147927717 | chr2:186206135-186206136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576286771 | chr2:186206163-186206164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544134651 | chr2:186206350-186206351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs850883 | chr2:186206370-186206371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs850884 | chr2:186206392-186206393 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs544763925 | chr2:186206431-186206432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs562999835 | chr2:186206435-186206436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564969867 | chr2:186206483-186206484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189308319 | chr2:186206526-186206527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs181350267 | chr2:186206538-186206539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs850885 | chr2:186206558-186206559 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs186304281 | chr2:186206578-186206579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190532590 | chr2:186206611-186206612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531499245 | chr2:186206643-186206644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551703981 | chr2:186206685-186206686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566949967 | chr2:186206697-186206698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186203600-186207400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:186236800-186237200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:186236800-186237800 | Enhancers | Adipose Nuclei | Adipose |
4 | chr2:186237200-186237600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr2:186237200-186237600 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr2:186237600-186238000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr2:186237600-186238600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
8 | chr2:186238000-186238200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr2:186239200-186239400 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr2:186241200-186241400 | Enhancers | Pancreas | Pancrea |
11 | chr2:186241200-186242000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr2:186242000-186242200 | Enhancers | Pancreas | Pancrea |